How Has Uğur Şahin’s Wealth Changed in 2021?

BioNTech, based in Germany and co-founded by a Turkish couple, continues to win since the day it launched the coronavirus vaccine with a brand new technology. The company that produces and distributes the most vaccines worldwide, in total in 2021 how much income you got explained.

According to the fourth quarter of 2021 and the general 2021 data shared by BioNTech, the company will increase its total revenue in 2021. 19 billion euro revenue achieved. The company’s if it is net profit 10.3 billion euros declared as. The company also shared its performance and expectations for 2021 and 2022.

In 2022, it is aimed to generate 13-17 billion dollars revenue from vaccines:

According to the information in the report, BioNTech sent a total of 2.6 billion doses of coronavirus vaccine to 165 countries in 2021. In 2022, the company announced that it will send 2.4 billion doses of the vaccine, according to the orders agreed so far. Also for the income he will get from the vaccines he will send in 2022. 13 billion – 17 billion euro range set as the target.

How has the fortune of Uğur Şahin, one of the Turkish founding partners of BioNTech, changed?

With the appreciation of BioNTech, Uğur Şahin’s fortune, which is now listed in the billionaires index, experienced ups and downs in 2021 depending on the company’s share value. Şahin, which is reported to have an 18% share in BioNTech, $5 billion fortune he had. Uğur Şahin’s wealth reached $19.1 billion in August 2021, with the huge rise in the company’s shares. Wealth, which has fallen in parallel with the company shares, is expected to reach 2021. It closed with $11.2 billion.

Uğur Şahin has been in his fortune since the beginning of 2022. Loss of $3.83 billion lived.